Kristen Rhodin

Journal article Clin Cancer Res · April 15, 2026 PURPOSE: Circulating tumor DNA (ctDNA) has emerged as an important biomarker for early recurrence detection and disease status monitoring during treatment in patients with cancer, including melanoma. We evaluate the prognostic value and impact of postopera ... Full text Link to item Cite

Management of In-transit Disease: Regional Therapies, Intralesional Therapies, and Systemic Therapy.

Journal article Surg Oncol Clin N Am · July 2025 In-transit (IT) melanoma represents a distinct, heterogeneous pattern of disease that arises as superficial tumors along the track between the primary site and the draining regional lymph node basin. Many therapies have been explored for treatment of this ... Full text Link to item Cite

View All Scholarly Works